Mirion Technologies MIR Medical Segment — D&A
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Mirion Technologies in its filing.
Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.
The official record: Mirion Technologies’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirion Technologies's medical segment — d&a.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Mirion Technologies's medical segment — D&A?
- Mirion Technologies (MIR) reported medical segment — D&A of $16.2M in Q1 2026.
- How has Mirion Technologies's medical segment — D&A changed year-over-year?
- Mirion Technologies's medical segment — D&A decreased by 1.2% year-over-year, from $16.4M to $16.2M.
- What is the long-term trend for Mirion Technologies's medical segment — D&A?
- Over 3 years (2022 to 2025), Mirion Technologies's medical segment — D&A has grown at a -7.4% compound annual growth rate (CAGR), from $82.4M to $65.5M.
- What does medical segment — D&A mean?
- Represents the systematic allocation of the cost of tangible and intangible assets over their useful lives within the Medical segment. This non-cash expense reflects the wear and tear of equipment and the consumption of acquired intangible assets like patents or customer relationships. It is a critical component for understanding the segment's asset intensity and for reconciling operating income to cash flow.